Some studies demonstrated that the addition of several biomarkers, such as NT-proBNP, hs-troponin T, d-dimer, IL-6 and troponin I, could improve the accuracy of the CHA2DS2-VASc score for predicting stroke and mortality in AF patients.12 This evidence concerns the gene NPPB and stroke disorder.